Blue Owl Capital Holdings LP Cullinan Oncology, Inc. Transaction History
Blue Owl Capital Holdings LP
- $377 Million
- Q1 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 2,924,842 shares of CGEM stock, worth $51 Million. This represents 13.21% of its overall portfolio holdings.
Number of Shares
2,924,842
Previous 3,419,842
14.47%
Holding current value
$51 Million
Previous $34.8 Million
43.02%
% of portfolio
13.21%
Previous 8.79%
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
118Shares Held
42.8MCall Options Held
12.6KPut Options Held
4.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$133 Million21.33% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$59.5 Million15.23% of portfolio
-
Bvf Inc San Francisco, CA3.2MShares$55.8 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA2.7MShares$47 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.43MShares$42.4 Million0.0% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $795M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...